Lisa Nolan serves as Executive at REXAHN PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Lisa Nolan has executed 3 insider transactions totaling $13.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 28, 2019 involved exercising options for 1,625 shares valued at $0.
Lisa Nolan currently holds 23,250 shares of REXAHN PHARMACEUTICALS, INC. (RNN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lisa Nolan has been a net buyer of RNN stock. They have purchased $13.0K and sold $0 worth of shares.
Lisa Nolan's most recent insider trade was on Feb 28, 2019, when they sold 1,625 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.65 |
| Discretionary |
| Feb 28, 2018 | RNN | $0 | Option Exercise | 1,625 | $N/A | Discretionary |